Bernard Ngara • UCSF Profiles (original) (raw)

  1. Translational Modeling of BTZ-043 to Predict Phase 2A Efficacy and Evaluate Drug-Drug Interactions With Bedaquiline, Pretomanid, and Linezolid in Murine Models. J Infect Dis. 2025 Jun 02; 231(5):e901-e911. Ngara B, Flori L, van Wijk RC, Ernest JP, Tyagi S, Soni H, Hölscher C, Walter K, Dreisbach J, Hoelscher M, Nuermberger EL, Savic RM. PMID: 39957252; PMCID: PMC12128049.
    View in: PubMed Mentions: Fields:
    Translation:HumansAnimals
  2. Predicting tuberculosis drug efficacy in preclinical and clinical models from in vitro data. iScience. 2025 Mar 21; 28(3):111932. Goh JJN, Patel A, Ngara B, van Wijk RC, Strydom N, Wang Q, Van N, Washington TM, Nuermberger EL, Aldridge BB, Roubert C, Sarathy J, Dartois V, Savic RM. PMID: 40034847; PMCID: PMC11875147.
    View in: PubMed Mentions:
  3. Prevalence and factors associated with uptake of pre-exposure prophylaxis amongst women vulnerable to HIV who received HIV antibodies in Antibody Mediated Prevention HVTN703/HPTN081 trial in Harare, Zimbabwe: a cross-sectional study. BMJ Public Health. 2024 Jul; 2(1). Siziba B, Mgodi NM, Ngara B, Chawana TD, Chitukuta M, Mukwekwerere PG, Bhondai-Mhuri M, Chirenje ZM, Mhlanga FGS. PMID: 39149557; PMCID: PMC11326454.
    View in: PubMed Mentions:
  4. Non-booking for antenatal care and risks for vertical HIV transmission among women in Chitungwiza, Zimbabwe: a cross-sectional study. BMC Pregnancy Childbirth. 2022 Nov 05; 22(1):817. Mandima P, Schaay N, Ngara B, Lembani M. PMID: 36335299; PMCID: PMC9636641.
    View in: PubMed Mentions: Fields:
    Translation:HumansPHPublic Health
  5. Impact of Motivational Enhanced Adherence Counseling and Point-of-Care Viral Load Monitoring on Viral Load Outcome in Women on Life-Long ART: A Randomized Pilot Study. AIDS Res Treat. 2022; 2022:4887202. Mutambanengwe-Jacob MT, Maponga CC, Amico KR, Ngara B, Yende-Zuma N, Chawana TD, Nematadzira T, Gumbo JF, Goverayi T, Matibe P, Malunda BV, Aizire J, Taha TE, Fowler MG, Stranix-Chibanda L. PMID: 36105074; PMCID: PMC9467808.
    View in: PubMed Mentions:
  6. Risk of mortality in HIV-infected COVID-19 patients: A systematic review and meta-analysis. J Infect Public Health. 2022 Jun; 15(6):654-661. Dzinamarira T, Murewanhema G, Chitungo I, Ngara B, Nkambule SJ, Madziva R, Herrera H, Mukwenha S, Cuadros DF, Iradukunda PG, Mashora M, Tungwarara N, Rwibasira GN, Musuka G. PMID: 35617829; PMCID: PMC9110010.
    View in: PubMed Mentions: 21 Fields:
    Translation:Humans
  7. Importation and distribution of unregistered medicines in the public sector: similarities, differences, and shared challenges among Southern African Development Community (SADC) countries. BMC Health Serv Res. 2022 Apr 28; 22(1):570. Nyika A, Ngara B, Mutingwende I, Gwaza L. PMID: 35484525; PMCID: PMC9047363.
    View in: PubMed Mentions: 4 Fields:
    Translation:Humans
  8. Risk Factors for COVID-19 Infection Among Healthcare Workers. A First Report From a Living Systematic Review and meta-Analysis. Saf Health Work. 2022 Sep; 13(3):263-268. Dzinamarira T, Nkambule SJ, Hlongwa M, Mhango M, Iradukunda PG, Chitungo I, Dzobo M, Mapingure MP, Chingombe I, Mashora M, Madziva R, Herrera H, Makanda P, Atwine J, Mbunge E, Musuka G, Murewanhema G, Ngara B. PMID: 35433073; PMCID: PMC9004144.
    View in: PubMed Mentions: 37
  9. COVID-19 Prevalence among Healthcare Workers. A Systematic Review and Meta-Analysis. Int J Environ Res Public Health. 2021 Dec 23; 19(1). Dzinamarira T, Murewanhema G, Mhango M, Iradukunda PG, Chitungo I, Mashora M, Makanda P, Atwine J, Chimene M, Mbunge E, Mapingure MP, Chingombe I, Musuka G, Nkambule SJ, Ngara B. PMID: 35010412; PMCID: PMC8750782.
    View in: PubMed Mentions: 39 Fields:
    Translation:HumansCells
  10. Regulation of medicines advertisement in Zimbabwe: an assessment of the impact of pharmaceutical promotion on the prescribing behaviour of healthcare professionals. BMC Health Serv Res. 2021 Dec 14; 21(1):1337. Semu TC, Ngara B, Mudzviti T. PMID: 34903223; PMCID: PMC8670253.
    View in: PubMed Mentions: 1 Fields:
    Translation:Humans
  11. Brief Report: Ritonavir Concentrations in Hair Predict Virologic Outcomes in HIV-Infected Adolescents With Virologic Failure on Atazanavir-Based or Ritonavir-Based Second-Line Treatment. J Acquir Immune Defic Syndr. 2021 10 01; 88(2):181-185. Chawana TD, Nhachi CFB, Nathoo K, Ngara B, Okochi H, Louie A, Kuncze K, Katzenstein D, Metcalfe J, Gandhi M, Adolescent Treatment Failure (ATF) Study Team. PMID: 34117162; PMCID: PMC8434943.
    View in: PubMed Mentions: 2 Fields:
    Translation:Humans
  12. Pharmacokinetic-pharmacodynamic modelling of atazanavir in hair among adolescents on antiretroviral treatment in Zimbabwe. BMC Pharmacol Toxicol. 2021 05 24; 22(1):29. Ngara B, Zvada S, Chawana TD, Nhachi CFB, Rusakaniko S. PMID: 34030726; PMCID: PMC8147021.
    View in: PubMed Mentions: Fields:
    Translation:Humans
  13. Risk factors for COVID-19 among healthcare workers. A protocol for a systematic review and meta-analysis. PLoS One. 2021; 16(5):e0250958. Dzinamarira T, Mhango M, Dzobo M, Ngara B, Chitungo I, Makanda P, Atwine J, Nkambule SJ, Musuka G. PMID: 33945546; PMCID: PMC8096084.
    View in: PubMed Mentions: 13 Fields:
    Translation:HumansCellsPHPublic Health
  14. Short Communication: Higher Tenofovir Concentrations in Hair Are Associated with Decreases in Viral Load and Not Self-Reported Adherence in HIV-Infected Adolescents with Second-Line Virological Treatment Failure. AIDS Res Hum Retroviruses. 2021 10; 37(10):748-750. Chawana T, Nhachi C, Nathoo K, Ngara B, Okochi H, Louie A, Kuncze K, Katzenstein D, Metcalfe J, Gandhi M. PMID: 33499754; PMCID: PMC8573801.
    View in: PubMed Mentions: 3 Fields:
    Translation:Humans
  15. A population pharmacokinetic model is beneficial in quantifying hair concentrations of ritonavir-boosted atazanavir: a study of HIV-infected Zimbabwean adolescents. BMC Pharmacol Toxicol. 2020 08 03; 21(1):58. Ngara B, Zvada S, Chawana TD, Stray-Pedersen B, Nhachi CFB, Rusakaniko S. PMID: 32746923; PMCID: PMC7398395.
    View in: PubMed Mentions: 3 Fields:
    Translation:Humans
  16. Perspectives on oral pre-exposure prophylaxis use amongst female sex workers in Harare, Zimbabwe. South Afr J HIV Med. 2020; 21(1):1039. Mudzviti T, Dhliwayo A, Chingombe B, Ngara B, Monera-Penduka TG, Maponga CC, Morse GD. PMID: 32158559; PMCID: PMC7059237.
    View in: PubMed Mentions: 3
  17. Defining a Cutoff for Atazanavir in Hair Samples Associated With Virological Failure Among Adolescents Failing Second-Line Antiretroviral Treatment. J Acquir Immune Defic Syndr. 2017 09 01; 76(1):55-59. Chawana TD, Gandhi M, Nathoo K, Ngara B, Louie A, Horng H, Katzenstein D, Metcalfe J, Nhachi CFB, Adolescent Treatment Failure (ATF) study team. PMID: 28520618; PMCID: PMC5552420.
    View in: PubMed Mentions: 18 Fields:
    Translation:Humans
  18. Genotypic diversity of anogenital human papillomavirus in women attending cervical cancer screening in Harare, Zimbabwe. J Med Virol. 2017 09; 89(9):1671-1677. Dube Mandishora RS, Christiansen IK, Chin'ombe N, Duri K, Ngara B, Rounge TB, Meisal R, Ambur OH, Palefsky JM, Stray-Pedersen B, Chirenje ZM. PMID: 28390142.
    View in: PubMed Mentions: 11 Fields:
    Translation:HumansCells
  19. Evaluating an enhanced adherence intervention among HIV positive adolescents failing atazanavir/ritonavir-based second line antiretroviral treatment at a public health clinic. J AIDS HIV Res. 2017 Jan; 9(1):17-30. Chawana TD, Katzenstein D, Nathoo K, Ngara B, Nhachi CFB. PMID: 31649827; PMCID: PMC6812532.
    View in: PubMed Mentions: 7
  20. HIV-1 Disease Progression and Survival in an Adult Population in Zimbabwe: Is There an Effect of the Mannose Binding Lectin Deficiency? OMICS. 2015 Sep; 19(9):542-52. Zinyama-Gutsire RB, Chasela C, Kallestrup P, Rusakaniko S, Christiansen M, Ngara B, Gomo E, Ullum H, Erikstrup C, Madsen HO, Stray-Pedersen B, Garred P, Mduluza T. PMID: 26348711; PMCID: PMC4575510.
    View in: PubMed Mentions: 2 Fields:
    Translation:HumansCells
  21. CYP2B6*6, CYP2B6*18, Body weight and sex are predictors of efavirenz pharmacokinetics and treatment response: population pharmacokinetic modeling in an HIV/AIDS and TB cohort in Zimbabwe. BMC Pharmacol Toxicol. 2015 Mar 27; 16:4. Dhoro M, Zvada S, Ngara B, Nhachi C, Kadzirange G, Chonzi P, Masimirembwa C. PMID: 25889207; PMCID: PMC4405819.
    View in: PubMed Mentions: 37 Fields:
    Translation:Humans
  22. Genetic variants of drug metabolizing enzymes and drug transporter (ABCB1) as possible biomarkers for adverse drug reactions in an HIV/AIDS cohort in Zimbabwe. Curr HIV Res. 2013 Sep; 11(6):481-90. Dhoro M, Ngara B, Kadzirange G, Nhachi C, Masimirembwa C. PMID: 24517233.
    View in: PubMed Mentions: 7 Fields:
    Translation:Humans

This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.

This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.

Start with: newest oldestInclude: line numbers double spacing all authors publication IDs